Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Papa MedicalPAPA Days Sales Outstanding is 1.04 as of Mar. 2025.
Papa Medical's average Accounts Receivable for the
three
months ended in Mar. 2025 was $0.20 Mil. Papa Medical's Revenue for the
three
months ended in Mar. 2025 was $17.87 Mil.
Hence, Papa Medical's Days Sales Outstanding for the
three
months ended in Mar. 2025 was 1.04.
The historical rank and industry rank for Papa Medical's Days Sales Outstanding or its related term are showing as below:
PAPA's Days Sales Outstanding is not ranked *
in the Tobacco Products industry.
Industry Median: 39.26 * Ranked among companies with meaningful Days Sales Outstanding only.
Papa Medical's Days Sales Outstanding
declined
from Mar. 2024 (3.79) to Mar. 2025 (1.04).
Papa Medical (NAS:PAPA) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Papa Medical Days Sales Outstanding Related Terms
Papa Medical Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Papa Medical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Tobacco subindustry, Papa Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Papa Medical Days Sales Outstanding vs Tobacco Products Industry
For the Tobacco Products industry and Consumer Defensive sector, Papa Medical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Papa Medical's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Papa Medical (PAPA) has a Days Sales Outstanding of 1.04 as of Mar. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Papa Medical and its competitors.
Is Papa Medical's Days Sales Outstanding too high?
Papa Medical's current Days Sales Outstanding is 1.04. The Tobacco Products industry median Days Sales Outstanding is 39.26. Papa Medical's value of 1.04 is 97.4% below this industry median.
How does Papa Medical's Days Sales Outstanding compare to ?
Papa Medical's Days Sales Outstanding of 1.04 can be compared against companies in the Tobacco Products industry. The industry median Days Sales Outstanding is 39.26. Papa Medical's value of 1.04 is 97.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Tobacco Products company?
The median Days Sales Outstanding among Tobacco Products companies is 39.26, based on 45 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Papa Medical's current Days Sales Outstanding of 1.04 is 97.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Papa Medical and its competitors. For the Tobacco Products industry, the median Days Sales Outstanding is 39.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Papa Medical's current Days Sales Outstanding is 1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current Days Sales Outstanding of 1.04. The current Days Sales Outstanding is 1.04 and 97.4% below the Tobacco Products industry median of 39.26. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Papa Medical (PAPA), the current Days Sales Outstanding is 1.04 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PAPA has been successfully added to your 
